Xerosis and pruritus as major EGFRI-associated adverse events

Author(s):
Clabbers, J.M.K.; Boers-Doets, C.B.; Gelderblom, H.; Stijnen, T. (0000-0001-9733-969X); Lacouture, M.E.; Hoeven, K.J.M. van der; Kaptein, A.A.
Published
2016
Publication type
Article / Letter to editor
CancerQuality of lifeEpidermal growth factor receptor inhibitorPapulopustular eruptionXerosisPruritus
Date issued
2016-02-28
Language
English
Is part of
Supportive Care in Cancer (2016), Vol. 24, no. 2, p. 513-521
hdl
1887/107958
doi
10.1007/s00520-015-2781-y